SavedAdd your journal

Journals / MN Oftalmoloji / 2006 / Cilt: 13 - Sayı: 3

Bimatoprost 0.03% versus apraclonidine 0.5% for the control of intraocular pressure elevation following Nd:YAG laser posterior capsulotomy

Nd:YAG lazer srka kapsülotomi sonrası göz içi basınç artışının kontrolünde %0.03’lük bimatoprost ve %0.5’lik apraklonidinin karşılaştırılması

TONGABAY CUMURCU
İLKER ETİKAN
HELİN DENİZ DEMİR
Pages
185–188
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study support that bimatoprost is a safe and effective as apraclonidine in the prevention of the IOP elevation after Nd:YAG laser posterior capsulotomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the efficacy of bimatoprost compared to apraclonidine the prevention of the intraocular pressure (IOP) elevation after Nd:YAG laser posterior capsulotomy.
📊
Key Findings & Data:Material and Methods: In a double masked prospective clinical study, 60 eyes from 60 patients were randomly assigned to receive either bimatoprost 0.03% or apraclonidine 0.5% one hour before Nd:YAG laser capsulotomy.
💡
Conclusion & Impact:Conclusion: This study support that bimatoprost is a safe and effective as apraclonidine in the prevention of the IOP elevation after Nd:YAG laser posterior capsulotomy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lazerler · katı-hal · Çift kör metot

Abstract

Purpose: To evaluate the efficacy of bimatoprost compared to apraclonidine the prevention of the intraocular pressure (IOP) elevation after Nd:YAG laser posterior capsulotomy. Material and Methods: In a double masked prospective clinical study, 60 eyes from 60 patients were randomly assigned to receive either bimatoprost 0.03% or apraclonidine 0.5% one hour before Nd:YAG laser capsulotomy. IOP was measured by a masked observer,using Goldmann applanation tonometry before 1 hour and 30 minutes,1 hour, 2 hour, 4 hour, 1 day and 1 week after the laser. Results: There were no statistically significant differences between the two groups regarding the IOP levels 30 minutes,1 hour before the procedure, and 1 hour, 2 hours, 4 hours, 1 day and 1 week after the laser treatment (p values, respectively : 0.582, 0.446, 0.839, 0.365, 0.698 and 0.739 ). Conclusion: This study support that bimatoprost is a safe and effective as apraclonidine in the prevention of the IOP elevation after Nd:YAG laser posterior capsulotomy.

Özet

Amaç: Nd:YAG lazer arka kapsülotomi sonrası göz içi basınç (GİB) artışının kontrolünde bimatoprostun etkinliğni değerlendirmek ve apraklonidin ile karşılaştırmak. Gereç ve Yöntem: Çift kör ve prospektif olarak yapılan çalışmaya 60 hastanın 60 gözü dahil edildi. Nd:YAG lazer kapsülotomiden 1 saat önce hastalar rastgele bimatoprost %0.03 ve apraklonidin % 0.5 tedavisi uygulanacak biçimde ayrıdı. GİB, grupları bilmeyen bir oftalmolog tarafından Goldmann aplanasyon tonometrisi kullanılarak, uygulamadan 1 saat, 30 dak. önce ve 1 saat, 2 saat, 4 saat, 1 gün ve 1 hafta sonra ölçüldü. Bulgular: Lazer uygulama öncesi 30. dak. ve 1. saat ile, uygulama sonrası 1. saat, 2. saat, 4. saat, 1.gün ve 1. hafta gruplar arası GİB farkı istatistiksel olarak anlamlı değildi (p değerleri sırası ile 0.582, 0.446, 0.839, 0.365, 0.698 ve 0.739). Sonuç: Çalışmamız Nd:YAG lazer arka kapsülotomi sonrası GİB artışının kontrolünde %0.03’lük bimatoprostun %0.5’lik apraklonidin kadar etkin ve güvenilir olduğunu gösterdi.

🔖

Cite This Article

CUMURCU, T., ETİKAN, İ., DEMİR, H. D. (2006). Bimatoprost 0.03% versus apraclonidine 0.5% for the control of intraocular pressure elevation following Nd:YAG laser posterior capsulotomy. MN Oftalmoloji, Cilt: 13 - Sayı: 3, 185–188. https://ajindex.com/articles/295832

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Richter CU, Arzeno G,. Pappas HR, et al. Intraocular pressure elevation following Nd: YAG laser posterior capsu-lotomy. Ophthalmology 1985; 92:636-40.
  2. Channel MM, Beckman H. intraocular pressure changes after neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 1984; 102:1024-6.
  3. Esgin H, Benian Ö, Mısır M, Alımlıgil ML, Erda S. Sekonder kataraktlarda Nd:YAG lazer arka kapsülotomi sonuçları ve komplikasyonları. MN-Oftalmoloji Dergisi 1999; 6:212-15.
  4. Okudan S, Gündüz K, Özbayrak N, Okka M, Zengin N, Acaroğlu Ş, Özkağnıcı A. Nd:YAG lazer posterior kapsülotomi sonuçlarımız. MN-Oftalmoloji Dergisi 1998; 5:80-1.
  5. Pollack IP, Brown RH, Crandall AS. Prevention of the rise following Neodymium:YAG laser posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol 1988;- 106;754-7. Robin AL Short term effects of unilateral 1% apraclonidine therapy. Arch Ophthalmol 1988; 106: 912-5. Cantor LB. Bimatoprost a member of a new class of agents the prostamides, for glaucoma management. Expert Opin Investig Drugs 2001; 10:721-31.
  6. Woodward DF, Krauss AH-P, Chen J. Replacement of the carboxylic acid group of prostaglandin F2a with a hydroxyl or methoxy substituent provides biologically unique compounds. Br J Pharmacol 2000; 130:1933-43.
  7. Yu M, Ives D, Ramesha CS: Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxigenase-2. J Biol Chem 1997; 272:21181-6.
  8. Solomovic AR, Parrish RK II. Acute elevation of intraocular pressure following Nd:YAG laser posterior capsulotomy. Ophthalmology 1985; 92:973-6.
  9. Parker WT, Clorfeine GS, Stocklin RD. Marked intraocular pressure rice following Nd:YAG laser posterior capsulotomy. Ophthalmic Surg 1984; 15:103-4.
  10. Ficker LA, Steele AD. Complications of Nd:YAG laser posterior capsulotomy. Trans Ophthalmol Soc UK 1985; 104:529-31.
  11. Terry AC, Stark WJ, Quigley HA, Radulovic D and Maumenee E. Decreased aqueous outflow, the mechanisms for elevated intraocular pressure following Nd:YAG capsulotomy. Ophthalmology 1984; 91:86. Hotchkiss ML, Quigley HA, Robin AL, Pollack IP and Green WR. YAG laser posterior capsulotomy. Primate studies ARVO abstracts. Supplement to invest. Ophthalmol Vis Sci 1984; 25:95. Silverstone DE, Brint SF, Olander KW, et all. Prophilactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies. Am J Ophthalmol 1992; 113:401-5.
  12. Serdahl CL, Galustian J, Lewis RA. The effects of aproclonidine on conjunctival oxygen tension. Arch Ophthalmol 1989; 107:1777. Gharagozloo NZ, Relf SJ,